SS
VNDA icon

Steve Schonfeld’s Vanda Pharmaceuticals VNDA Stock Holding History

Steve Schonfeld’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-59,107
Closed -$521K – 2713
2025
Q4 		$521K Buy
+59,107
New +$325K ﹤0.01% 1379
2025
Q2 		– Sell
-379,001
Closed -$1.74M – 2577
2025
Q1 		$1.74M Buy
379,001
+108,460
+40% +$506K 0.01% 1021
2024
Q4 		$1.3M Buy
+270,541
New +$1.3M 0.01% 1012
2023
Q4 		– Sell
-22,241
Closed -$96.1K – 2254
2023
Q3 		$96.1K Buy
+22,241
New +$124K ﹤0.01% 1499
2022
Q4 		– Sell
-49,991
Closed -$494K – 3043
2022
Q3 		$494K Buy
+49,991
New +$528K ﹤0.01% 1762
2021
Q4 		– Sell
-10,000
Closed -$172K – 2571
2021
Q3 		$172K Buy
+10,000
New +$175K ﹤0.01% 1812
2020
Q1 		– Sell
-14,284
Closed -$235K – 1550
2019
Q4 		$235K Buy
+14,284
New +$216K 0.01% 1095
2016
Q4 		– Sell
-43,169
Closed -$719K – 658
2016
Q3 		$719K Buy
+43,169
New +$581K 0.12% 227

Other funds holding VNDA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Steve Schonfeld's VNDA Position: Q1 2026 in Review

Steve Schonfeld sold out of Vanda Pharmaceuticals (VNDA) in Q1 2026, closing a stake of 59,107 shares — an estimated $521K sold.

Steve Schonfeld first reported a position in VNDA in Q3 2016 and held it in 8 quarters. The position peaked at $1.74M in Q1 2025. 171 funds tracked by Wall St. Rank hold VNDA as of Q1 2026.

  • Steve Schonfeld reported no remaining Vanda Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Steve Schonfeld sold 59,107 Vanda Pharmaceuticals shares in Q1 2026, an estimated $521K.
  • Steve Schonfeld first reported a position in Vanda Pharmaceuticals in Q3 2016 and held it in 8 quarters.
  • Steve Schonfeld's Vanda Pharmaceuticals position peaked at $1.74M in Q1 2025.
  • 171 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q1 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.